The in vivo effect of elevated free fatty acids (FFA) on -cell function in humans remains extremely controversial. We examined, in healthy young men, the acute (90 min) and chronic (48 h) effects of an approximately twofold elevation of plasma FFA vs. control on glucose-stimulated insulin secretion (GSIS). GSIS was studied in response to a graded intravenous glucose infusion (peak plasma glucose, ~10 mmol/l, n = 8) and a two-step hyperglycemic clamp (10 and 20 mmol/l, n = 8). In the acute studies, GSIS was significantly higher, insulin sensitivity index (S_I) was lower, and disposition index (DI = insulin sensitivity × insulin secretion) was unchanged with elevated FFA vs. control [2-step clamp: DI = 8.9 ± 1.4 × 10³ l² · kg¹ · min² in control vs. 10.0 ± 1.9 × 10³ l² · kg¹ · min² with high FFA, P = nonsignificant (NS)]. In the chronic studies, there was no difference in absolute GSIS between control and high FFA studies, but there was a reduction in S_I and a loss of the expected compensatory increase in insulin secretion as assessed by the DI (2-step clamp: DI = 10.0 ± 1.2 × 10³ l² · kg¹ · min² in control vs. 6.1 ± 0.7 × 10³ l² · kg¹ · min² with high FFA, P = 0.01). In summary, 1) acute and chronic FFA elevation induces insulin resistance; 2) with acute FFA elevation, this insulin resistance is precisely countered by an FFA-induced increase in insulin secretion, such that DI does not change; and 3) chronic FFA elevation disables this -cell compensation.

pancreatic -cell; diabetes; insulin resistance; disposition index

This article has been cited by other articles:

				C. Xiao, A. Giacca, and G. F. Lewis The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and {beta}-cell dysfunction in overweight and obese nondiabetic men Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1205 - E1211. [Abstract] [Full Text] [PDF]

				B. Salgin, M. L. Marcovecchio, S. M. Humphreys, N. Hill, L. J. Chassin, D. J. Lunn, R. Hovorka, and D. B. Dunger Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E454 - E461. [Abstract] [Full Text] [PDF]

				S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598. [Abstract] [Full Text] [PDF]

				K. Cusi, S. Kashyap, A. Gastaldelli, M. Bajaj, and E. Cersosimo Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1775 - E1781. [Abstract] [Full Text] [PDF]

				A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda, A. Mari, and R. A. DeFronzo Thiazolidinediones improve beta-cell function in type 2 diabetic patients Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E871 - E883. [Abstract] [Full Text] [PDF]

				T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560. [Abstract] [Full Text] [PDF]

				C. Santangelo, P. Matarrese, R. Masella, M. C. Di Carlo, A. Di Lillo, B. Scazzocchio, E. Vecci, W. Malorni, R. Perfetti, and E. Anastasi Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress J. Mol. Endocrinol., January 1, 2007; 38(1): 147 - 158. [Abstract] [Full Text] [PDF]

				H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097. [Abstract] [Full Text] [PDF]

				A. Larbi, A. Grenier, F. Frisch, N. Douziech, C. Fortin, A. C Carpentier, and T. Fulop Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans Am. J. Clinical Nutrition, November 1, 2005; 82(5): 949 - 956. [Abstract] [Full Text] [PDF]

				A. C. Carpentier, F. Frisch, D. Cyr, P. Genereux, B. W. Patterson, R. Giguere, and J.-P. Baillargeon On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E849 - E856. [Abstract] [Full Text] [PDF]

				R. Lupi, S. Del Guerra, L. Marselli, M. Bugliani, U. Boggi, F. Mosca, P. Marchetti, and S. Del Prato Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR{gamma}2 in the modulation of insulin secretion Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E560 - E567. [Abstract] [Full Text] [PDF]

				N. Stefan, M. Stumvoll, C. Bogardus, and P. A. Tataranni Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1156 - E1161. [Abstract] [Full Text] [PDF]

				T. M. Wolever and C. Mehling Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance Am. J. Clinical Nutrition, March 1, 2003; 77(3): 612 - 621. [Abstract] [Full Text] [PDF]

				E. Qvigstad, I. L. Mostad, K. S. Bjerve, and V. E. Grill Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E129 - E137. [Abstract] [Full Text] [PDF]

				C. Beysen, A. K. Belcher, F. Karpe, B. A. Fielding, E. Herrera, and K. N. Frayn Novel experimental protocol to increase specific plasma nonesterified fatty acids in humans Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E18 - E24. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, H. Yoshii, C. A. Haber, E. Bogdanovic, L. Lam, I. G. Fantus, and A. Giacca Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E682 - E691. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats Diabetes, June 1, 2002; 51(6): 1825 - 1833. [Abstract] [Full Text] [PDF]

				S. M. Chalkley, M. Hettiarachchi, D. J. Chisholm, and E. W. Kraegen Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1231 - E1238. [Abstract] [Full Text] [PDF]

				A. Carpentier, B. W. Patterson, K. D. Uffelman, A. Giacca, M. Vranic, M. S. Cattral, and G. F. Lewis The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism Diabetes, June 1, 2001; 50(6): 1402 - 1413. [Abstract] [Full Text]